Samantha Williams,Kirsten Pondman,Praveen M. Varghese,Ahmad Al Aiyan,Uday Kishore,Robert B. Sim
Abstract:Factor B, a serine protease proenzyme and part of the complement system, binds to other complement proteins such as C3b and properdin. While it is known to be activated by factor D, other interactions that interfere with the binding between Factor B and C3b are less well-understood. We attached C3b to a thiol Sepharose via its free SH group and conducted a competition assay employing I-labelled factor B to study competitive binding. Two anti-C3d monoclonal antibodies (F49b and 4C2) were found to partially inhibit the binding of Factor B to C3b. The inhibitory effects of these monoclonal antibodies were found to be dose-dependent. 4C2 was found to have a maximum inhibition of 50%, while the maximum inhibition by F49b was ∼40%. In contrast, two anti-C3c monoclonal antibodies (F39b and F20b) were able to enhance the formation of the factor B-C3b complex in a dose-dependent manner. Competition binding studies with isolated C3 fragments further supported the involvement of the C3d region in factor B binding, as C3d inhibited the binding of factor B to C3b completely. Furthermore, additional competition binding studies conducted with each of the three domains of factor B (Ba, vWF and SP) demonstrated that each domain independently inhibited the binding of intact factor B to C3b by ∼50%.
What problem does this paper attempt to address?
This paper aims to study the interaction between factor B and C3b in the human complement system. Specifically, the researchers carried out competitive binding experiments using radio - labeled factor B by immobilizing C3b on thiol - agarose to explore various factors affecting the binding of factor B to C3b. These factors include the effects of salt concentration, pH value, metal ion concentration and time. In addition, the study also explored the effects of monoclonal antibodies against different regions of C3 on the binding of factor B to C3b, as well as the effects of different domains of factor B on its binding to C3b.
### Research Background
The complement system is an important part of innate immunity and is mainly composed of a variety of soluble and membrane - bound proteins. Depending on the activation trigger, the complement system can be activated through the classical pathway, the lectin pathway and the alternative pathway. One of the key features of the alternative pathway is the spontaneous deposition of C3b on the surface of pathogens, a process that does not depend on specific targets. C3 is cleaved into C3b during complement activation, and complement factor B is a 90 - kDa glycoprotein present in human plasma that can form a complex with C3b and is cleaved into two fragments, Ba and Bb, under the action of factor D. Bb temporarily binds to C3b to form the C3 convertase C3bBb, which is further stabilized by factor H to activate more C3.
### Research Objectives
1. **Explore the binding conditions of factor B and C3b**: The researchers observed the effects of these conditions on the binding of factor B to C3b by changing the salt concentration, pH value, metal ion concentration and binding time.
2. **Evaluate the effects of monoclonal antibodies**: The researchers used monoclonal antibodies against the C3c and C3d regions to evaluate the effects of these antibodies on the binding of factor B to C3b.
3. **Analyze the roles of different domains of factor B**: The researchers isolated and purified the Ba, vWF and SP domains of factor B and tested their effects on the binding of factor B to C3b respectively.
### Main Findings
- **Binding conditions**: The binding of factor B to C3b is the strongest at low salt concentration, acidic pH (pH 4.7) and high magnesium ion concentration. In the presence of EDTA, the binding strength is lower, but the binding is still observable.
- **Effects of monoclonal antibodies**: The monoclonal antibodies F49b and 4C2 against the C3d region partially inhibited the binding of factor B to C3b, while the monoclonal antibodies F20b and F39b against the C3c region enhanced the binding.
- **Roles of factor B domains**: The Ba, vWF and SP domains of factor B independently inhibited the binding of intact factor B to C3b, with an inhibition rate of about 50%.
### Conclusion
This study, through detailed experimental design and data analysis, has revealed multiple factors affecting the binding of factor B to C3b, providing important basic data for further understanding the functions and mechanisms of the complement system.